Estamos no ar no ! Saiba mais
ícone de OTLK

Outlook Therapeutics

Nome Posição Valor negociado Variação na
qtd. de ações
Variação na
participação
SM
1
Sabby Management
Florida
US$ 7,04 mi +US$ 7,71 mi +12.931 Nova
Perceptive Advisors
2
Perceptive Advisors
New York
US$ 4,46 mi +US$ 4,89 mi +8.205 Nova
Cormorant Asset Management
3
Cormorant Asset Management
Massachusetts
US$ 3,49 mi +US$ 3,83 mi +6.420 Nova
Avoro Capital Advisors
4
Avoro Capital Advisors
New York
US$ 1,59 mi +US$ 1,74 mi +2.917 Nova
Sphera Funds Management
5
Sphera Funds Management
Israel
US$ 881 mil +US$ 966 mil +1.619 Nova
Marshall Wace
6
Marshall Wace
United Kingdom
US$ 851 mil +US$ 933 mil +1.564 Nova
Acuta Capital Partners
7
Acuta Capital Partners
California
US$ 828 mil +US$ 907 mil +1.521 Nova
PointState Capital
8
PointState Capital
New York
US$ 680 mil +US$ 746 mil +1.250 Nova
Jefferies Group
9
Jefferies Group
New York
US$ 540 mil +US$ 592 mil +992 Nova
Millennium Management
10
Millennium Management
New York
US$ 300 mil +US$ 329 mil +551 Nova
Hudson Bay Capital Management
11
Hudson Bay Capital Management
Connecticut
US$ 213 mil +US$ 233 mil +391 Nova
Monashee Investment Management
12
Monashee Investment Management
Massachusetts
US$ 170 mil – – –
Morgan Stanley
13
Morgan Stanley
New York
US$ 34 mil +US$ 37,6 mil +63 Nova
UBS Group
14
UBS Group
Switzerland
US$ 5 mil +US$ 5,37 mil +9 Nova
Tower Research Capital (TRC)
15
Tower Research Capital (TRC)
New York
US$ 2 mil +US$ 2,39 mil +4 Nova
Wells Fargo
16
Wells Fargo
California
– +US$ 596 +1 Nova